In vitro assessment of antimicrobial agents against toxoplasma gondii

Carol Harris, Miklos P. Salgo, Herbert B. Tanowitz

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

We have modified a method of quantitating growth of Toxoplasma organisms by measuring incorporation of [3H]uracil into Toxop/asma-mfeacd, differentiated L6E9 rat myocytes and have found that low-dose pyrimethamine (0.1 µg/ml) and sulfadiazine (25 µg/ml) are synergistic. Pyrimethamine at higher concentrations (0.5 and 1.0 µg/ml) inhibits uptake to the same degree as the low-dose pyrimethamine-sulfadiazine combination. Spiramycin was effective only at high concentrations (200 µ g/ml) and with prolonged incubation of >72 h. Clindamycin and several of its analogues, methotrexate and difluoromethylor- nithine, were all ineffective and showed no additive effect with either pyrimethamine or sulfadiazine. Spirogermanium, an experimental antineoplastic and antiprotozoan agent, was effective only at concentrations close to those toxic to the system. 5-Fluorouracil was effective even at 0.1 µ g/ml. At 0.01 (µ g/ml it was synergistic with pyrimethamine (0.1 xg/ml), and the combination was as effective as high-dose pyrimethamine (1.0 µg/ml).

Original languageEnglish (US)
Pages (from-to)14-22
Number of pages9
JournalJournal of Infectious Diseases
Volume157
Issue number1
DOIs
StatePublished - Jan 1988

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro assessment of antimicrobial agents against toxoplasma gondii'. Together they form a unique fingerprint.

  • Cite this